Filed: 2/12/2026ACC: 0001999371-26-003198
📋 What this filing means
GSK PLC filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $799.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$799.02M
Total AUM (reported)
51.05M
Total Shares
Allocation by class
SHS$310.18M38.8%
NAMEN AKT$168.89M21.1%
COM$156.23M19.6%
SPONSORED ADS$95.54M12.0%
COM NEW$68.19M8.5%
Portfolio Concentration
Top 3$563.78M70.6%
4–10$218.29M27.3%
11–25$16.96M2.1%
Top 3 weight
70.6%
Top 10 weight
97.9%
Voting Authority Distribution
Total shares with voting rights: 51.05M
Sole
Full voting authority
51.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
WAVE LIFE SCIENCES LTD
SOLEShares18.25M
TypeSH
Market value$310.18M
38.82%
Sole
18.25M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares3.22M
TypeSH
Market value$168.89M
21.14%
Sole
3.22M
Shared
0.00
None
0.00
BIONTECH SE
SOLEShares889.82K
TypeSH
Market value$84.71M
10.60%
Sole
889.82K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares8.55M
TypeSH
Market value$51.56M
6.45%
Sole
8.55M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares1.51M
TypeSH
Market value$46.56M
5.83%
Sole
1.51M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares1.33M
TypeSH
Market value$46.09M
5.77%
Sole
1.33M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares340.43K
TypeSH
Market value$21.63M
2.71%
Sole
340.43K
Shared
0.00
None
0.00
SPERO THERAPEUTICS INC
SOLEShares9.19M
TypeSH
Market value$21.41M
2.68%
Sole
9.19M
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares1.79M
TypeSH
Market value$20.20M
2.53%
Sole
1.79M
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares1.53M
TypeSH
Market value$10.83M
1.36%
Sole
1.53M
Shared
0.00
None
0.00
CVRX INC
SOLEShares1.01M
TypeSH
Market value$7.15M
0.90%
Sole
1.01M
Shared
0.00
None
0.00
NKARTA INC
SOLEShares3.15M
TypeSH
Market value$5.83M
0.73%
Sole
3.15M
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares271.46K
TypeSH
Market value$3.91M
0.49%
Sole
271.46K
Shared
0.00
None
0.00
SENSEONICS HLDGS INC
SOLEShares10.86K
TypeSH
Market value$59.9K
<0.01%
Sole
10.86K
Shared
0.00
None
0.00
HARVARD BIOSCIENCE INC
SOLEShares11.15K
TypeSH
Market value$7.5K
<0.01%
Sole
11.15K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
WAVE LIFE SCIENCES LTDSOLE | SHS | 18.25M | SH | $310.18M 38.82% | 18.25M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 3.22M | SH | $168.89M 21.14% | 3.22M | 0.00 | 0.00 |
BIONTECH SESOLE | SPONSORED ADS | 889.82K | SH | $84.71M 10.60% | 889.82K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 8.55M | SH | $51.56M 6.45% | 8.55M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM NEW | 1.51M | SH | $46.56M 5.83% | 1.51M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 1.33M | SH | $46.09M 5.77% | 1.33M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 340.43K | SH | $21.63M 2.71% | 340.43K | 0.00 | 0.00 |
SPERO THERAPEUTICS INCSOLE | COM | 9.19M | SH | $21.41M 2.68% | 9.19M | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 1.79M | SH | $20.20M 2.53% | 1.79M | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 1.53M | SH | $10.83M 1.36% | 1.53M | 0.00 | 0.00 |
CVRX INCSOLE | COM | 1.01M | SH | $7.15M 0.90% | 1.01M | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 3.15M | SH | $5.83M 0.73% | 3.15M | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 271.46K | SH | $3.91M 0.49% | 271.46K | 0.00 | 0.00 |
SENSEONICS HLDGS INCSOLE | COM | 10.86K | SH | $59.9K <0.01% | 10.86K | 0.00 | 0.00 |
HARVARD BIOSCIENCE INCSOLE | COM | 11.15K | SH | $7.5K <0.01% | 11.15K | 0.00 | 0.00 |